We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » USTR Review of India’s IP Rights to Focus Largely on Pharma
USTR Review of India’s IP Rights to Focus Largely on Pharma
The Office of the U.S. Trade Representative is conducting a review of India’s intellectual property regime that focuses in large part on pharma IP issues, including access to affordable medicines.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor